Statement of comprehensive income for the year ended 31 March 2024
| Note | 2023/24 £000 | 2022/23 £000 | |
| Operating income from patient care activities | 2.1 / 2.2 | 163,594 | 148,223 |
| Other operating income | 2.5 | 12,639 | 12,038 |
| Total operating income from continuing operations | 176,233 | 160,261 | |
| Operating expenses | 3.1 | (167,234) | (159,485) |
| Operating surplus | 8,999 | 776 |
Finance costs
| Finance income | 5.1 | 2,407 | 904 |
| Finance expense | 5.2 | (139) | (115) |
| PDC Dividends payable | (2,310) | (1,940) | |
| Net finance costs | (42) | (1,151) |
| Loss on disposal of assets | 5.5 | (49) | (15) |
| Surplus / (deficit) for the year from continuing operations | 8,908 | (390) |
Other comprehensive income
Will not be reclassified to income and expenditure:
| Impairments on property, plant and equipment and donated assets | 14.1 | (528) | (5) |
| Revaluation gains on property, plant and equipment and donated assets | 14.1 | 2,716 | 2,971 |
| Total other comprehensive income | 2,188 | 2,966 |
| Total comprehensive income for the year | 11,096 | 2,576 |
There are no minority interests in the Trust therefore the net surplus for the year of £8,908,000 (2022/23: deficit of £390,000) and the total comprehensive income for the year of £11,096,000 (2022/23: £2,576,000) is wholly attributable to the Trust.
The notes from page 126 form part of these accounts.
All income and expenditure is derived from continuing operations.
